Usefulness of urinary kidney injury molecule-1 (Kim-1) as a biomarker for cisplatin-induced sub-chronic kidney injury

Journal of Applied Toxicology

Volumn 35, Issue 2, 2015, Pages 124-132

  Nan ya, Ken ichiro ^a,b   Kajihara, Masatomo ^a   Kojima, Natsuki ^a   Degawa, Masakuni ^b  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Cisplatin; Kim 1; Rat; Sub chronic kidney injury; Urinary biomarkers

Indexed keywords

CISPLATIN; CREATININE; KIDNEY INJURY MOLECULE 1; OSTEOPONTIN; UREA; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; HAVCR1PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; HISTOPATHOLOGY; KIDNEY INJURY; MALE; NONHUMAN; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RAT; SUBCHRONIC KIDNEY INJURY; UREA NITROGEN BLOOD LEVEL; ANIMALS; BLOOD; BLOOD UREA NITROGEN; CHEMICALLY INDUCED; DRUG EFFECTS; KIDNEY; PATHOLOGY; RATS; RENAL INSUFFICIENCY, CHRONIC; URINE;

RATTUS;

ANIMALS; BIOLOGICAL MARKERS; BLOOD UREA NITROGEN; CELL ADHESION MOLECULES; CISPLATIN; CREATININE; KIDNEY; MALE; RATS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84919875421     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.2999     Document Type: Article

References (45)

1. Arany I, Safirstein RL. 2003. Cisplatin Nephrotoxicity. Semin. Nephrol. 23: 460-464.
2. Bonventre JV, Vaidya VS, Schmouder R, Feig P, Dieterle F. 2010. Next-generation biomarkers for detecting kidney toxicity. Nat. Biotechnol. 28: 436-440.
3. Chevalier RL. 1996. Growth factors and apoptosis in neonatal ureteral obstruction. J. Am. Soc. Nephrol. 7: 1098-1105.
4. Correa-Rotter R, Ibarra-Rubio ME, Schwochau G, Cruz C, Silkensen JR, Pedraza-Chaverri J, Chmielewski D, Rosenberg ME. 1998. Induction of clusterin in tubules of nephrotic rats. J. Am. Soc. Nephrol. 9: 33-37.
5. Davis II JW, Goodsaid FM, Bral CM, Obert LA, Mandakas G, Garner II CE, Collins ND, Smith RJ, Rosenblum IY. 2004. Quantitative gene expression analysis in a nonhuman primate model of antibiotic-induced nephrotoxicity. Toxicol. Appl. Pharmacol. 200: 16-26.
6. Dieterle F, Sistare F, Goodsaid F, Papaluca M, Ozer JS, Webb CP, Baer W, Senagore A, Schipper MJ, Vonderscher J, Sultana S, Gerhold DL, Phillips JA, Maurer G, Carl K, Laurie D, Harpur E, Sonee M, Ennulat D, Holder D, Andrews-Cleavenger D, Gu Y, Thompson KL, Goering PL, Vidal J, Abadie E, Maciulaitis R, Jacobson-Kram D, Defelice AF, Hausner EA, Blank M, Thompson A, Harlow P, Throckmorton D, Xiao S, Xu N, Taylor W, Vamvakas S, Flamion B, Lima BS, Kasper P, Pasanen M, Prasad K, Troth S, Bounous D, Robinson-Gravatt D, Betton G, Davis MA, Akunda J, McDuffie JE, Suter L, Obert L, Guffroy M, Pinches M, Jayadev S, Blomme EA, Beushausen SA, Barlow VG, Collins N, Waring J, Honor D, Snook S, Lee J, Rossi P, Walker E, Mattes W. 2010a. Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium. Nat. Biotechnol. 28: 455-462.
7. Dieterle F, Perentes E, Cordier A, Roth DR, Verdes P, Grenet O, Pantano S, Moulin P, Wahl D, Mahl A, End P, Staedtler F, Legay F, Carl K, Laurie D, Chibout S, Vonderscher J, Maurer G. 2010b. Urinary clusterin, cystatin C, β2-microglobulin and total protein as markers to detect drug-induced kidney injury. Nat. Biotechnol. 28: 463-469.
8. Fenoglio C, Boncompagni E, Chiavarina B, Cafaggi S, Cilli M, Viale M. 2005. Morphological and histochemical evidence of the protective effect of procainamide hydrochloride on tissue damage induced by repeated administration of low doses of cisplatin. Anticancer Res. 25: 4123-4128.
9. Fuchs TC, Hewitt P. 2011. Preclinical perspective of urinary biomarkers for the detection of nephrotoxicity: what we know and what we need to know. Biomark. Med. 5: 763-779.
10. Fuchs TC, Frick K, Emde B, Czasch S, von Landenberg F, Hewitt P. 2012. Evaluation of novel acute urinary rat kidney toxicity biomarker for subacute toxicity studies in preclinical trials. Toxicol. Pathol. 540: 1031-1048.
11. Gautier J, Riefke B, Walter J, Kurth P, Mylecraine L, Guilpin V, Barlow N, Gury T, Hoffman D, Ennulat D, Schuster K, Harpur E, Pettit S. 2010. Evaluation of novel biomarkers of nephrotoxicity in two strains of rat treated with cisplatin. Toxicol. Pathol. 38: 943-956.
12. González R, Romay C, Borrego A, Hernández F, Merino N, Zamora Z, Rojas E. 2005. Lipid peroxides and antioxidant enzymes in cisplatin-induced chronic nephrotoxicity in rats. Mediators Inflamm. 3: 139-143.
13. Harding MA, Chadwick LJ, Gattone II VH, Calvet JP. 1991. The SGP-2 gene is developmentally regulated in the mouse kidney and abnormally expressed in collecting duct cysts in polycystic kidney disease. Dev. Biol. 146: 483-490.
14. Harpur E, Ennulat D, Hoffman D, Betton G, Gautier J, Riefke B, Bounous D, Schuster K, Beushausen S, Guffroy M, Shaw M, Lock E, Pettit S. 2011. Biological qualification of biomarkers of chemical-induced renal toxicity in two strains of male rat. Toxicol. Sci. 122: 235-252.
15. Hart SGE. 2005. Assessment of renal injury in vivo. J. Pharmacol. Toxicol. Methods 52: 30-45.
16. Hoffmann D, Adler M, Vaidya VS, Rached E, Mulrane L, Gallagher WM, Callanan JJ, Gautier JC, Matheis K, Staedtler F, Dieterle F, Brandenburg A, Sposny A, Hewitt P, Ellinger-Ziegelbauer H, Bonventre JV, Dekant W, Mally A. 2010a. Performance of novel kidney biomarkers in preclinical toxicity studies. Toxicol. Sci. 116: 8-22.
17. Hoffmann D, Fuchs TC, Henzler T, Matheis KA, Herget T, Dekant W, Hewitt P, Mally A. 2010b. Evaluation of a urinary kidney biomarker panel in rat models of acute and subchronic nephrotoxicity. Toxicology 277: 49-58.
18. Hosohata K, Ando H, Fujimura A. 2012. Urinary vanin-1 as a novel biomarker for early detection of drug-induced acute kidney injury. J. Pharmacol. Exp. Ther. 341: 656-662.
19. Huo W, Zhang K, Nie Z, Li Q, Jin F. 2010. Kidney injury molecule-1 (KIM-1): a novel kidney-specific injury molecule playing potential double-edged functions in kidney injury. Transplant. Rev. 24: 143-146.
20. Ichimura T, Bonventre JV, Bailly V, Wei H, Hession CA, Cate RL, Sanicola M. 1998. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J. Biol. Chem. 273: 4135-4142.
21. Ichimura T, Asseldonk EJP, Humphreys BD, Gunaratnam L, Duffield JS, Bonventre JV. 2008. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J. Clin. Invest. 118: 1657-1668.
22. Kharasch ED, Schroeder JL, Bammler T, Beyer R, Srinouanprachanh S. 2006. Gene expression profiling of nephrotoxicity from the sevoflurane degradation product fluoromethyl-2, 2-difluoro-1-(trifluoromethyl)vinyl ether ("Compound A") in rats. Toxicol. Sci. 90: 419-431.
23. Kramer AB, van Timmeren MM, Schuurs TA, Vaidya VS, Bonventre JV, van Goor H, Navis G. 2009. Reduction of proteinuria in adriamycin-induced nephropathy is associated with reduction of renal kidney injury molecule (Kim-1) over time. Am. J. Physiol. Renal Physiol. 296: F1136-F1145.
24. Kuehn EW, Park KM, Somlo S, Bonventre JV. 2002. Kidney injury molecule-1 expression in murine polycystic kidney disease. Am. J. Physiol. Renal Physiol. 283: F1326-F1336.
25. Kuhlmann MK, Burkhardt G, Köhler H. 1997. Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol. Dial. Transplant. 12: 2478-2480.
26. Marrer E, Dieterle F. 2010. Impact of biomarker development on drug safety assessment. Toxicol. Appl. Pharmacol. 243: 167-179.
27. Pfaller W, Gstraunthaler G. 1998. Nephrotoxicity testing in vitro-what we know and what we need to know. Environ. Health Perspect. 106: 559-569.
28. Pinches M, Betts C, Bickerton S, Burdett L, Thomas H, Derbyshire N, Jones HB, Moores M. 2012. Evaluation of novel renal biomarkers with a cisplatin model of kidney injury: gender and dosage differences. Toxicol. Pathol. 40: 522-533.
29. Proulx NL, Akbari A, Garg AX, Rostom A, Jaffey J, Clark HD. 2005. Measured creatinine clearance from timed urine collections substantially overestimates glomerular filtration rate in patients with liver cirrhosis: a systematic review and individual patient meta-analysis. Nephrol. Dial. Transplant. 20: 1617-1622.
30. Prozialeck WC, Vaidya VS, Liu J, Waalkes MP, Edwards JR, Lamar PC, Bernard AM, Dumont X, Bonventre JV. 2007. Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxicity. Kidney Int. 72: 985-993.
31. Rosenberg ME, Silkensen J. 1995. Clusterin: Physiologic and pathophysiologic considerations. Int. J. Biochem. Cell Biol. 27: 633-645.
32. Rouse RL, Zhang J, Stewart SR, Rosenzweig BA, Espandiari P, Sadrieh NK. 2011. Comparative profile of commercially available urinary biomarkers in preclinical drug-induced kidney injury and recovery in rats. Kidney Int. 79: 1186-1197.
33. Sasaki D, Yamada A, Umeno H, Kurihara H, Nakatsuji S, Fujihira S, Tsubota K, Ono M, Moriguchi A, Watanabe K, Seki J. 2011. Comparison of the course of biomarker changes and kidney injury in a rat model of drug-induced acute kidney injury. Biomarkers 16: 553-566.
34. Swain A, Turton J, Scudamore C, Maguire D, Pereira I, Freitas S, Smyth R, Munday M, Stamp C, Gandhi M, Sondh S, Ashall H, Francis I, Woodfine J, Bowles J, York M. 2011. Nephrotoxicity of hexachloro-1:3-butadiene in the male Hanover Wistar rat; correlation of minimal histopathological changes with biomarkers of renal injury. J. Appl. Toxicol. 32: 417-428.
35. van Timmeren MM, van den Heuvel MC, Bailly V, Bakker SJL, van Goor H, Stegeman CA. 2007. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J. Pathol. 212: 209-217.
36. Tonomura Y, Tsuchiya N, Torii M, Uehara T. 2010. Evaluation of the usefulness of urinary biomarkers for nephrotoxicity in rats. Toxicology 273: 53-59.
37. Urbschat A, Obermüller N, Haferkamp A. 2011. Biomarkers of kidney injury. Biomarkers 16: S22-S30.
38. Vaidya VS, Ramirez V, Ichimura T, Bobadilla NA, Bonventre JV. 2006. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am. J. Physiol. Renal Physiol. 290: F517-F529.
39. Vaidya VS, Ferguson MA, Bonventre JV. 2008. Biomarkers of acute kidney injury. Annu. Rev. Pharmacol. Toxicol. 48: 463-493.
40. Vaidya VS, Ozer JS, Dieterle F, Collings FB, Ramirez V, Troth S, Muniappa N, Thudium D, Gerhold D, Holder DJ, Bobadilla NA, Marrer E, Perentes E, Cordier A, Vonderscher J, Maurer G, Goering PL, Sistare FD, Bonventre JV, 2010. Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat. Biotechnol. 28: 478-485.
41. Vinken P, Starckx S, Barale-Thomas E, Looszova A, Sonee M, Goeminne N, Versmissen L, Buyens K, Lampo A. 2012. Tissue Kim-1 and urinary clusterin as early indicators of cisplatin-induced acute kidney injury in rats. Toxicol. Pathol. 40: 1049-1062.
42. Witzgall R, Brown D, Schwarz C, Bonventre JV. 1994. Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J. Clin. Invest. 93: 2175-2188.
43. Xie Y, Sakatsume M, Nishi S, Narita I, Arakawa M, Gejyo F. 2001. Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int. 60: 1645-1657.
44. Yu Y, Jin H, Holder D, Ozer JS, Villarreal S, Shughrue P, Shi S, Figueroa DJ, Clouse H, Su M, Muniappa N, Troth SP, Bailey W, Seng J, Aslamkhan AG, Thudium D, Sistare FD, Gerhold DL. 2010. Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury. Nat. Biotechnol. 28: 470-477.
45. Zhou Y, Vaidya VS, Brown RP, Zhang J, Rosenzweig BA, Thompson KL, Miller TJ, Bonventre JV, Goering PL. 2008. Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Toxicol. Sci. 101: 159-170.